La migration cellulaire est un phénomène essentiel au développement, à l'immunité et à la cicatrisation. Pourtant, l'activation des programmes de migration en dehors des situations physiologiques peut avoir des effets néfastes. Par exemple, la migration cellulaire permet aux cellules d'une tumeur primaire d'envahir de nouveaux territoires et d'installer des tumeurs secondaires ou métastases. Lorsqu'une migration cellulaire est initiée à partir d'un tissu épithélial, ces cellules doivent acquérir des caractéristiques mésenchymateuses. Pour cela, elles diminuent leur adhérences cellule-cellule, perdent leur polarité apico-basale, réorganisent leur cytosquelette, changent d'adhérence à la matrice et modifient la composition et l'organisation de la matrice. C'est ce qu'on appelle la transition épithélio-mésenchymateuse (TEM). La famille des Métalloprotéinases Matricielle (MMP) est connue pour participer au remodelage de la matrice. Les MMPs sont au nombre de 25 et sont sécrétées ou membranaires. L'une de ces MMP membranaires est MMP14 ou MT1-MMP. Elle participe à la migration physiologique et pathologique via la dégradation de composants de la matrice. Elle dégrade également des protéines non matricielles sécrétées ou membranaires. De plus, MMP14 agit indépendamment de son activité catalytique en régulant par exemple l'activation de petites GTPases, de voies de signalisation et en contrôlant l'expression de gênes. Cependant, beaucoup d'études sur MMP14 ont été faites in vitro et ex vivo et il n'est pas clair si toutes les fonctions de MMP14 sont retrouvées in vivo. Plus spécifiquement les fonctions possibles de MMP14 dans la TEM et la migration in vivo sont encore mal définies. Nous proposons d'utiliser les crêtes neurales (CN) de l'embryon de poulet comme modèle pour étudier MMP14 au cours de la TEM et de la migration in vivo. Les CN sont des cellules embryonnaires retrouvées dans la partie dorsale du tube neural. Les CN réalisent une TEM pour quitter le tube neural avant de parcourir de longues distances et donner de nombreux types cellulaires. Les CN se séparent en deux populations, les CN céphaliques retrouvées dans la tête et les CN troncales dans le reste de l'embryon. Ces deux populations de CN réalisent des TEM différentes, avec une TEM rapide et massive pour les CN céphaliques et plus lente et en continue pour les CN troncales. Même si ces TEM sont différentes, elles présentent une diminution des jonctions cellulaires, une perte de la polarité apico-basale, un changement d'adhérence à la matrice et une réorganisation de la matrice. Une particularité des CN troncales est la localisation du noyau en position basale de l'épithélium juste avant la sortie du tube neural. Plusieurs substrats de MMP14 sont retrouvés dans la TEM et la migration des CN et une étude a montré par PCR la présence de l'ARNm de MMP14 dans les CN céphaliques de poulet. L'objectif de la thèse est d'explorer la fonction de MMP14 au cours de la TEM et de la migration des CN. Nous avons montré que MMP14 est exprimée dans les deux populations de CN au cours de la TEM et de la migration. / Cell migration is an essential event during embryonic development, immunity and wound healing. Furthermore, the activation of migration program in non-physiologic conditions can have side effects. For example, cell migration promotes invasion of primary tumor cells in new territories and the formation of secondary tumors or metastasis. When an epithelial tissue initiates migration, epithelial cells need to gain mesenchymal attributes. To this end, they decrease their cell-cell adhesions, loss their apico-basal polarity, reorder their cytoskeleton, change their matrix adhesions and modify the matrix composition and organization. This event is named epithelial-mesenchymal transition (EMT). The family of Matrix Metalloproteinase (MMP) is known to reshape the matrix. MMP family is composed of 25 members which are secreted or linked to the membrane. One of the membrane-bound MMP is MMP14 or MT1-MMP. MMP14 is known to promote physiological and pathologic cell migration by inducing degradation of numerous matrix components. MMP14 cleaves also non-matrix proteins which are secreted or membrane-bound. Moreover, MMP14 can act independently of its catalytic activity for example in the regulation of small GTPases, signaling pathway and in gene expression control. However, the vast majority of MMP14 related studies were conducted in vitro or ex vivo and it is not clear whether some of its functions occur in vivo. More specifically, MMP14's putative functions in EMT and migration are still ill-defined. We propose to use the Neural Crest (NC) of chick embryo as model to study MMP14 during in vivo EMT and migration. NC is an embryonic cell population located in the dorsal part of the neural tube. NC cells realize an EMT to leave the neural tube before performing a long-distance migration and producing a myriad of cell types as neurons, bones and cartilages of the face and pigment cells. NC cells are divided in two populations, the cephalic NC in embryo's head and the trunk NC in the posterior part. The cephalic NC perform a fast and massive EMT while the trunk NC's EMT is slower and continuous. Although the EMT are different, they conserve common characteristics with a decrease of cell junctions, a loss of the apico-basal polarity, a change of matrix adherence and a rearrangement of the matrix. One particularity of trunk NC is the epithelium basal position of the nucleus just prior their exit from the neural tube. Many MMP14's substrates are found during NC EMT and migration and a study suggested by PCR that chick cephalic NC express MMP14 mRNA. The goal of this thesis is to explore the function of MMP14 during chick NC EMT and migration. Our results show that MMP14 is expressed by the two populations of NC during EMT and migration. Moreover, MMP14 cell localization changes from apical to basal during EMT. Loss of function experiments show that MMP14 is needed for NC EMT. Our rescues with various MMP14 versions indicate that: 1/ the cytoplasmic domain is not essential, 2/ the extracellular domain is needed and 3/ the catalytic activity is not required for EMT. MMP14 is involved in the control of cell junctions by a switch between cadherin-6B and cadherin-7 but not in the remodeling of the matrix during NC EMT. We have also showed that MMP14 is necessary for the change of cell polarity during EMT. Furthermore, we have showed that MMP14 is needed for the formation of matrix adherence. In conclusion, our study shows that MMP14 is involved in NC EMT and migration and that NC are a good model to investigate MMP14 function in vivo.

Tumour cell invasion is one of the most critical steps in malignant progression. It includes a broad spectrum of mechanisms, including both individual and collective cell migration, which enables them to spread towards adjacent tissue, and form new metastases. Understanding the mechanisms of cell spreading, and invasion, is crucial for effective anticancer therapy. Two modes of individual migration of tumour cells have been established in a three-dimensional environment. Mesenchymally migrating cells use proteases to cleave collagen bundles, and thus overcome the ECM barriers. Recently described protease-independent amoeboid mode of invasion has been discovered in studies of cancer cells with protease inhibitors. During my PhD study, I have focused on determining the molecular mechanisms involved in amoeboid invasion of tumour cells. We have examined invasive abilities in non-metastatic K2 and highly metastatic A3 rat sarcoma cell lines. We have shown that even though highly metastatic A3 rat sarcoma cells are of mesenchymal origin, they have upregulated Rho/ROCK signalling pathway. Moreover, A3 cells generate actomyosin-based mechanical forces at their leading edges to physically squeeze through the collagen fibrils by adopting an amoeboid phenotype. Amoeboid invasiveness is also less dependent on...

Cells can release lipid bilayer vesicles of endosomal and plasma membrane origin, which are known as exosomes or extracellular vesicles (EVs). EVs contain diverse shuttling lipids, RNA and transmembrane proteins, and play an important role in communicating between neighboring or distant cells. Breast cancer is the most commonly diagnosed malignancy, with over 2 million new cases in 2018, and is the leading cause of cancer mortality in women all over the world. Some observational studies have suggested that breast cancer is more likely to develop among women who have type 2 diabetes; the association is clear in postmenopausal women. Moreover, women with type 2 diabetes diagnosed before, at the same time, or after breast cancer diagnosis, have decreased overall survival compared to women without diabetes. The most recent medical studies provide more clues as to why breast cancer is more common and has poorer prognosis in type 2 diabetes patients, by pointing out the role of insulin-resistant adipocytes in the etiopathology. Here, we demonstrate how insulin-resistant adipocytes engage crosstalk with breast cancer cells through EVs in the microenvironment and drive the tumor cells to be more metastatic and aggressive. These progression mechanisms and the effects of insulin-resistant adipocytes on breast cancer cells require Bromodomain and ExtraTerminal (BET) proteins – an important epigenetic pathway. Targeting this pathway may help reduce morbidity and mortality of women with breast cancer and type 2 diabetes.

Breast cancer remains the most common malignant disease in women worldwide. Despite the advantages of early detection and improved treatments, studies into the mechanisms that initiate and drive breast cancer progression are still required. Recent studies have identified RUNX1, which is an essential transcription factor for hematopoiesis, is one of the most frequently mutated genes in breast cancer patients. However, the role of RUNX1 in the mammary gland is understudied. In this dissertation, we examined the role of RUNX1 in both normal mammary epithelial and breast cancer cells. Our in vitro studies demonstrated that RUNX1 inhibits epithelial to mesenchymal transition (EMT), migration, and invasion, reflecting its tumor suppressor activity, which was confirmed in vivo. Moreover, RUNX1 also contributes significantly to inhibition of the phenotypes of breast cancer stem cells (CSC), which is responsible for metastasis and tumor relapse. We showed that Runx1 overexpression reduces the tumorsphere formation and cancer stem cell population. Overall, our studies provide mechanistic evidence for RUNX1 repression of EMT in mammary cells, anti-tumor activity in vivo and regulation of CSC-like properties in breast cancer. Our results highlight crucial roles for RUNX1 in preventing epithelial to mesenchymal transition and tumor progression in breast cancer. This RUNX1 mediated mechanism points to novel intervention strategies for early stage breast cancer.

京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第21261号 / 医博第4379号 / 新制||医||1029(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 山下 潤, 教授 湊谷 謙司, 教授 羽賀 博典 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第21642号 / 医博第4448号 / 新制||医||1034(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 妹尾 浩, 教授 小川 誠司, 教授 坂井 義治 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

Inhibitor of Differentiation (ID) proteins are a family of four (ID1-4) bHLH transcription factors that lack the DNA binding domain. They act by forming dimers with other transcriptional regulators and inhibiting their interaction with DNA. They play a crucial role during embryonic development and later in the adulthood, their expression is mostly restricted to a few populations of stem cells. In the last decades, many authors have described their re-activation and participation in tumor development, angiogenesis and EMT although the results are still controversial. In the first chapter of this research work, the role of ID genes as prognostic markers in breast cancer was evaluated. We studied the mRNA expression of the four ID genes and four markers of EMT by qRT-PCR in a clinical series of 307 primary breast carcinomas previously stratified in immunophenotypes. In addition, the expression of all these genes was measured in breast cancer cell lines and mammospheres. Overexpression of at least one ID gene was found in 48.9% of the studied samples. ID1 and ID4 were overexpressed mostly in TNBL and HER2-enriched subtypes, whereas ID2 and ID3 were overexpressed more frequently in luminal tumors. High ID1 and ID4 was associated with larger tumor size, histological grade 3, presence of necrosis and vascular invasion, and poorer outcome. Multivariate analysis revealed that ID4 and vascular invasion were independent factors for DFS. Regarding EMT markers, high levels of SNAI1 were associated with the overexpression of the four ID genes. Additionally, ID1 overexpression was positively related to TWIST1, and the overexpression of ID2 and ID3 was more frequently paired with tumors that conserve CHD1 expression. In vitro studies showed high expression of the four ID genes in all cell lines. However, when mammospheres were formed, mRNA levels of ID genes decreased, in contrast to SNAI1 and TWIST1, which mostly increased. In the second chapter of this thesis, we aimed to (a) describe the mechanisms of action of a small molecule pan-ID antagonist, (b) define its main targets and (c) investigate potential pathways of acquire resistance. Treatment with AGX51 led to Id protein loss, increase in ROS accumulation, cell cycle arrest, and cell death in all tumor cell lines tested. Here, we used an antioxidant compound in different cell lines to demonstrate that ROS are the main responsible of cell death following treatment with AGX51. A model of cultured quiescent cells not expressing ID proteins served to show that the main target of AGX51 are these proteins. Experiments with AGX-derivatives also supported these results. Finally, three mutagenizing agents were used in order to generate mutations that confer resistance to treatment with AGX51. Treatment with ENU gave rise to two clones apparently resistant to AGX51 effects. Based on our in vitro and clinicopathological studies, we conclude that ID1 and ID4 may act as biomarkers of worse prognosis in patients with breast cancer, and seem to be involved in the initiation of EMT mechanism. Therefore, they are potential targets for the development of novel drugs. In line with this, AGX51 arises as a potent anti-ID compound that has anticancer effects.

京都大学 / 新制・課程博士 / 博士(医学) / 甲第24136号 / 医博第4876号 / 新制||医||1060(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 藤田 恭之, 教授 波多野 悦朗, 教授 伊藤 貴浩 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

No description available.

Digital image processing is widely used in the field of time-lapse microscopy and biological research to provide statistical data of cellular dynamics. The data can provide more comprehensive understanding of the molecular phenomenon. Further, digital image processing enables rapid and consistent quantification of qualitative observations. The image processing model examined here provides a study to identify structures called retraction fibers (RFs) that are formed during epithelial-mesenchymal transition (EMT) [1], an important developmental process which also occurs during cancer metastasis. Quantifying RF formation is an important task for biologists studying cellular regulation of EMT. This thesis work uses digital image processing and computer vision algorithms to detect and track each RF in image sequences of cells undergoing EMT that are captured using time-lapse microscopy. The algorithms isolate the RFs with reasonable precision. Statistical information is generated about these automatically detected RFs, such as the number formed during a particular time window, lifetime of each, and their geometric dimension. This information can in turn be used by biologists to quantitatively measure the extent of EMT under different test conditions. Biologists feel that the information thus obtained may help clarify the molecular interactions of cell migration and will aid in developing methods of preventing cancer metastasis. Experimental results show that this methodology has significant potential in helping biologists determine RF behavior during EMT.